LUMO

Lumos Pharma, Inc. Common Stock
LUMO

Overview Fund Activity
Delisted

LUMO was delisted on the 11th of December, 2024.

Back to rankings

35 hedge funds and large institutions have $23M invested in Lumos Pharma, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 9 reducing their positions, and 2 closing their positions.

Holders
35
Holders Change
-1
Holders Change %
-2.78%
% of All Funds
0.61%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
5
Reduced
9
Closed
2
Calls
$38K
Puts
–
Net Calls
+$38K
Net Calls Change
+$5K

Top Buyers

1
Goldman Sachs
1
Goldman Sachs
New York
$5.17M
2
KPF
2
K2 Principal Fund
Ontario, Canada
$494K
3
OM
3
Opaleye Management
Massachusetts
$412K
4
Wells Fargo
4
Wells Fargo
California
$2.89M
5
WFA
5
Wipfli Financial Advisors
Wisconsin
$9K

Top Sellers

1
NMC
1
NEA Management Company
Maryland
$0
2
WAOI
2
Wealth Advisors of Iowa
Iowa
$104K
3
Renaissance Technologies
3
Renaissance Technologies
New York
$2.22M
4
T. Rowe Price Associates
4
T. Rowe Price Associates
Maryland
$997K
5
PAG
5
Private Advisor Group
New Jersey
$151K
Name Holding Trade Value Shares
Change 		Shares
Change %
WFA
26
Wipfli Financial Advisors
Wisconsin
$9K +$9K +1,011 New
WFA
27
West Financial Advisors
Iowa
$7K – – –
UBS Group
28
UBS Group
Switzerland
$6K -$9.66K -1,194 -62%
Morgan Stanley
29
Morgan Stanley
New York
$3K – – –
Royal Bank of Canada
30
Royal Bank of Canada
Ontario, Canada
$2K -$1.28K -161 -39%
Northwestern Mutual Wealth Management
31
Northwestern Mutual Wealth Management
Wisconsin
$1K – – –
Group One Trading
32
Group One Trading
Illinois
$1K – – –
NMC
33
NEA Management Company
Maryland
– -$503K -65,374 Closed
CAPTRUST Financial Advisors
34
CAPTRUST Financial Advisors
North Carolina
– -$5K -621 Closed
1
2